This is being filed to report stroke, prolonged hospitalization, and medical intervention.It was reported that this was a mitraclip procedure to treat functional mitral regurgitation (mr) with a grade of 4.On (b)(6) 2020, one clip was successfully deployed, reducing mr to 2.There were no adverse patient effects and no reported clinically significant delay in the procedure.After the procedure, the patient was experiencing symptoms of cerebral infarction which is an indication of a possible stroke.It was noted that the patient was weak after awakening from general anesthesia.Angiography was performed and testing of the cerebral vessel condition was confirmed, and the physician determined the patient had stenosis.As of (b)(6) 2020, the patient continued to be on anticoagulants and the patient's condition improved.The patient recovered from the stroke.The physician stated that the relationship between the event and the clip is unknown.The clip remains stable on both leaflets, and mr is 2.The patient will remain hospitalized and discharged after rehabilitation.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot.The physical weakness is the result of the cerebrovascular accident.Based on the information provided a conclusive cause for the reported cerebrovascular accident cannot be determined.It is possible that the cerebrovascular accident is the result of the mitraclip procedure, however this cannot be conclusively determined.The reported patient effects of physical weakness and cerebrovascular accident as listed in the mitaclip system instructions for use are known possible complications associated with mitraclip procedures.Based on the information reviewed, there is no indication of a product issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.
|